ArticleDeutsches Arzteblatt international2008
Guideline-compatible treatment of breast cancer patients: the status quo in schleswig-holstein.
Article in Deutsches Arzteblatt international, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- [Compliance of patients concerning recommended radiotherapy in breast cancer : Association with recurrence, age, and hormonal therapy].Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2012Trial
- Contributing and limiting factors to guideline-adherent therapy in senior and elderly breast cancer patients: a questionnaire-based cross-sectional study using clinical and cancer registry data in Germany.Journal of cancer research and clinical oncology · 2023Article
- Treatment Quality in Breast Cancer: Numbers, Age, and Breast Reconstruction.Deutsches Arzteblatt international · 2015Article
- The Treatment of Primary Breast Cancer in Older Women With Adjuvant Therapy: A Retrospective Analysis of Data From Over 3000 Patients From the PATH Biobank, With Two-Year Follow-up.Deutsches Arzteblatt international · 2015Article
- Provision of breast cancer care and survival in Germany - results from a population-based high resolution study from Saarland.BMC cancer · 2014Article
- Guideline conformity treatment in young women with early-onset breast cancer in Germany.Breast care (Basel, Switzerland) · 2014Article
- Patients and Methods of the PATH Biobank - A Resource for Breast Cancer Research.Geburtshilfe und Frauenheilkunde · 2014Article
- Adopting Guidelines into Clinical Practice: Implementation of Trastuzumab in the Adjuvant Treatment of Breast Cancer in Lower Saxony, Germany, in 2007.Breast care (Basel, Switzerland)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionIt is unclear whether the care of breast cancer patients complies with the German breast cancer guideline and achieves the appropriate standard of care. For this reason the guideline's requirements were compared with the empirically determined health care provision in the German state of Schleswig-Holstein.
methodsThe OVIS-study is based on a postal questionnaire survey of medical care in 1927 breast cancer patients between 02/2003 to 02/2005. Statements such as "should be carried out" and "mandatory procedure" were cross-referenced with specific reference ranges.
resultsLocally invasive tumors were rare (pT 3/4: 8%). Preoperatively, 95% of patients received mammography, 78% breast ultrasound, 92% a chest x-ray, and 81% an abdominal ultrasound. 71% of all patients had breast conserving treatment, of whom 96% had irradiation of the remaining breast tissue. Axilla lymph node dissection was reported for 91%, axillary irradiation for 36%, and a systemic therapy for 95%. DISCUSSION: Local quality indicators comply in general with the German guideline. The high rate of axillary irradiation could be viewed as inadequate provision.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.